News and Announcements
Wayne State professor elected president-elect of the American College of Medical Genetics and Genomics
DETROIT - Gerald Feldman, M.D., Ph.D., F.A.C.M.G., Wayne State University School of Medicine professor of Molecular Medicine and Genetics, has been elected president-elect of the American College of Medical Genetics and Genomics.
Dr. Feldman, who also is a professor of Pediatrics and of Pathology, as well as director of Clinical Genetic Services, will serve as president-elect through March 2015, when he will become president of the college and hold that position through 2017.
The ACMG works to advance the practice of medical genetics and genomics by providing education, resources and a voice for more than 1,600 biochemical, clinical, medical and molecular geneticists, genetic counselors and other health care professionals. The organization advocates for quality genetic services in health care and in public health, and promotes the development of methods to diagnose, treat and prevent genetic disease.
“Medicine is undergoing an evolution in the diagnosis, management and treatment of disease using genetic and genomic information,” said Dr. Feldman, who lives in West Bloomfield, Mich., and also serves as medical director of the Division of Laboratory Genetics and Molecular Pathology at the Detroit Medical Center-University Laboratories. “It is both a challenge and a privilege to be the incoming president of the American College of Medical Genetics and Genomics, an organization dedicated to the practice of medical genetics and whose mission is to define and promote excellence in the practice of medical genetics and genomics.”
Dr. Feldman, who joined the WSU School of Medicine faculty1999, is program director for the Newborn Screening Metabolic Management Program at Children's Hospital of Michigan, and program director for the Medical Genetics Residency and the Medical Biochemical Genetics Fellowship programs at the Detroit Medical Center/Wayne State University School of Medicine.
He divides his time between the clinical practice of medical genetics and inborn errors of metabolism, molecular diagnostics, and medical genetics education and training.
The author of more than 80 peer-reviewed publications, book chapters and reviews, his research interests include fragile X syndrome and cystic fibrosis. More recently, his interests have focused on newborn screening, specifically in the area of long-term follow-up and management.
Dr. Feldman has a special interest in medical genetics education. In 2004, he was a co-organizer of the first Banbury Summit on the future of medical genetics training. He served as president of the Association of Professors of Human and Medical Genetics from 2006 to 2008. He has been chair and a member of Michigan's Genetic Advisory, Newborn Screening and Metabolic Quality Improvement committees, and has served on a number of ACMG committees, including as program chair of the 2007 annual Clinical Genetics Meeting and as director of Clinical Genetics from 2005 to 2011.
Wayne State University is one of the nation's pre-eminent public research universities in an urban setting. Through its multidisciplinary approach to research and education, and its ongoing collaboration with government, industry and other institutions, the university seeks to enhance economic growth and improve the quality of life in the city of Detroit, state of Michigan and throughout the world. For more information about research at Wayne State University, visit http://www.research.wayne.edu.